During mammalian embryogenesis, epithelial-mesenchymal interactions play a determining role in normal tissue patterning and development. Keratinocyte growth factor (KGF), a member of the ®broblast growth factor (FGF) family, is a mesenchymally-derived mitogen for epithelial cells. As the KGF receptor is expressed by epithelial cells of numerous tissues and KGF is produced in adjacent stromal cells, KGF is thought to play a role in mediating epithelial cell behaviour. To further investigate the role of this molecule in the development of ocular epithelia we employed transgenic mice engineered to overexpress human KGF in the eye. The most striking phenotypic development was the hyperproliferation of embryonic corneal epithelial cells and their subsequent differentiation into functional lacrimal gland-like tissues. This indicates that stimulation of the KGF receptor early in development, in surface ectoderm normally destined to form corneal epithelium, is suf®cient to alter the fate of these cells. Furthermore, this suggests that the correct spatial and temporal expression of FGFs plays a critical role in normal lacrimal gland induction. These transgenic mice provide a valuable model system to study the mechanisms underlying cell fate decisions during ocular morphogenesis. q
Introduction
During embryogenesis, bi-directional interactions and signalling between mesenchyme and epithelium are considered to be essential for morphogenesis, organogenesis, cell differentiation and growth (Grobstein, 1953; Sanders, 1988; Martin, 1998) . There is accumulating evidence for the involvement of polypeptide growth factors in embryonic induction, playing important roles in controlling cellular behaviour and differentiation decisions. In particular, various members of the ®broblast growth factor (FGF) gene family have been implicated in mesoderm induction and appear to play a role in early pattern formation (Kimelman and Kirschner, 1987; Slack et al., 1987; Paterno et al., 1989) as well as in epithelial-mesenchymal interactions (see Martin, 1998) . Expression studies of these genes at early and late stages of development indicate that they likely play important roles as signalling molecules throughout the life span of the organism (see Baird and Klagsbrun, 1991; Basilico and Moscatelli, 1992; Baird, 1994; Mason, 1994) . The FGFs constitute a large family of at least 18 distinct polypeptide growth factors (FGF-1 to FGF-18) which share distinct sequence homology (see Ohbayashi et al., 1998) . The FGFs mediate their pleiotropic actions by binding to and activating high af®nity membrane-spanning receptors which form a distinct subgroup of the receptor tyrosine kinase family (Johnson and Williams, 1993) . In mammals, four FGF receptor (FGFR1 to FGFR4) genes have been cloned and identi®ed (see Givol and Yayon, 1992; Johnson and Williams, 1993) . The products of these genes are structurally related and consist of an extracellular ligand binding region with two or three immunoglobulin (Ig) loops and an intracellular split tyrosine kinase domain. Although only four distinct FGF receptor genes have been described, alternative splicing of primary transcripts are capable of generating multiple FGFR isoforms, differing in structure and ligand af®nity (Johnson and Williams, 1993) . The second half of Ig domain III represents a site of alternative splicing. For example, at the FGFR2 locus, two variants are gener- Mechanisms of Development 88 (1999) 43±53 ated; FGFR2IIIb and FGFR2IIIc (Miki et al., 1992) . The temporal and spatial patterns of expression of the FGFR isoforms suggest that they play major roles in the speci®city of FGF bioactivation in a variety of tissues (Ledoux et al., 1992; Givol and Yayon, 1992; Chellaiah et al., 1994) .
Keratinocyte growth factor (KGF), also commonly known as FGF-7, is a unique member of the FGF family Finch et al., 1989) . It is a secreted, mesenchymally-derived growth factor that can function as a paracrine effector of normal epithelial cell proliferation and development Finch et al., 1989; Aaronson et al., 1991; Werner et al., 1994) . In contrast to the other FGFs, KGF interacts with only one FGFR isoform (FGFR2IIIb, also known as the KGF receptor, KGFR; see Ornitz et al., 1996) which is exclusively expressed by epithelial cells. This speci®city, together with the appositional expression patterns of KGF and KGFR in mouse embryos suggests that KGF plays a major role in mediating mesenchymalepithelial interactions during foetal development . Support for this comes from several studies. Guo et al. (1993) employed transgenic mice to target expression of KGF speci®cally to epidermal keratinocytes. KGF overexpression in these mice resulted in altered differentiation of skin as well as effects on hair follicle morphogenesis and salivary gland differentiation. A more recent study using transgenic mice overexpressing KGF in the liver demonstrated abnormalities in epithelial differentiation within multiple organ systems (Nguyen et al., 1996) . This is consistent with other studies examining the effects of systemic and localised administration of exogenous KGF on adult rat tissues, which showed it to stimulate the proliferation and differentiation of epithelial cells from numerous tissues (see Nguyen et al., 1996 for review) .
To investigate the consequence of overexpressing FGF during ocular development, a recent study in our laboratory generated different lines of transgenic mice, engineered to express different members of the FGF family, including KGF, speci®cally in the eye (Lovicu and Overbeek, 1998) . Overexpression of KGF in these transgenic mice predominantly in¯uenced the epithelium of the lens and cornea, with changes to the lens characterised by the formation of cataracts, resulting from the disruption of the normal polarity of the lens as epithelial cells inappropriately exited from the cell cycle and differentiated into ®bre cells (see Lovicu and Overbeek, 1998) . In the present study, we further characterise the ocular phenotype of these transgenic mice which exhibit dramatic changes in the pathway of differentiation of corneal epithelial cells, with KGF initially inducing epithelial hyperproliferation with subsequent differentiation into secretory, glandular tissues resembling lacrimal glands. These ®ndings suggest that embryonic corneal epithelial cells are competent to respond to KGF and that hyper-stimulation of the KGFR is suf®cient to alter the fate of these cells, leading to a progression along a different (glandular) developmental pathway.
Results
In the present study we examined two families of transgenic mice (OVE842 and OVE843) generated by microinjection of a construct containing a lens-speci®c a Acrystallin promoter linked to the human KGF cDNA (see Lovicu and Overbeek, 1998) . Using in situ hybridization, the speci®city of transgene expression was assayed using tissues from embryonic day 15.5 (E15.5) mice (Fig. 1) . A transgene-speci®c radiolabelled riboprobe against the 3 H untranslated SV40 region of the construct hybridised exclusively to the ocular lens of transgenic mice, with no transgene expression detected in the cornea and retina (Fig. 1) . Sense riboprobes transcribed from the same SV40 sequence did not show any speci®c hybridization in either transgenic or non-transgenic tissues (data not shown).
By postnatal day 21, mice from both the transgenic families display similar phenotypes characterised by severe ocular defects, including the formation of cataracts and the opaci®cation of the cornea. Although the transgene was strongly expressed in the lens at E15.5 (see Fig. 1 ), histological analysis did not detect a phenotype in the lens until Fig. 1 . Lens-speci®c transcription of transgene. A. Bright-®eld histology of an embryonic day 15.5 (E15.5) OVE842 transgenic eye stained with haematoxylin and eosin. B. In situ hybridization with an antisense 35 Slabelled riboprobe speci®c for the SV40 region of the transgenic construct. Dark-®eld microscopy shows high levels of transgene expression exclusively in the elongating ®bres of the lens (1). No transgene expression was detected in the surrounding ocular tissues, including the presumptive cornea (c) and retina (r). Scale bar, 400 mm.
after embryonic day 18.5 (see Lovicu and Overbeek, 1998) . In contrast to the lens, as early as E14.5, phenotypic changes were apparent in the ectoderm that normally gives rise to the corneal epithelium (Fig. 2) . In transgenic embryos, these presumptive corneal epithelial cells elongated to exhibit a columnar morphology (Fig. 2B,D ) when compared to agematched littermate controls that had a more cuboidal morphology ( Fig. 2A,C) . In addition, increased levels of BrdU incorporation (indicating a marked increase in cell proliferation) were evident in the presumptive corneal epithelium of the transgenic mice (Fig. 2F, arrows) when compared to non-transgenic littermates (Fig. 2E) .
A day later in development, at E15.5, the presumptive cornea in transgenic mice had undergone a dramatic thickening (Fig. 3B,D ) when compared to that of control littermates (Fig. 3A,C) . The increased thickening of this tissue resulted in exophthalmia with the eyes of transgenic mice protruding further out from the eye socket ( Fig. 3B ) than those from non-transgenic littermates (Fig. 3A) . The thickening of this corneal-like tissue was largely due to the multilayering of the epithelium as well as an increase in the number of cells comprising the underlying stroma ( Fig.  3D ). In the transgenic mice, high levels of BrdU-incorporation persisted in the strati®ed epithelium ( Fig. 3F) , with the majority of the proliferating cells localised to the basal layer (Fig. 3F, arrows) . Furthermore, the stroma underlying the epithelium demonstrated signs of vascularisation, evident by the small regions of eosinophilic-stained blood vessels (Fig. 3D, arrowheads) . The corneal stroma of non-transgenic littermates is avascular (Fig. 3C) .
As the presumptive corneal epithelium in our transgenic mice exhibited atypical morphological changes, we examined the expression of keratin 12 (K12; a marker for cornealtype epithelial differentiation, see Kao et al., 1996) to assess the differentiation state of the corneal epithelium. In eyes of non-transgenic mice, K12 is normally expressed speci®cally in the corneal epithelial cells and not in the¯anking epithelia that will give rise to the conjunctiva (Fig. 4A ). In contrast, in eyes of transgenic littermates, K12 was not expressed (Fig. 4B) .
By E16, growth of the eyelids in non-transgenic mice results in their closing and fusing over the eyeball. Although transgenic mice demonstrated exophthalmia at El5.5, in most cases the eyelids still managed to grow over the eyeball and fuse together (see Fig. 5B ). However, some transgenic mice were born with their eyes partially opened due to incomplete fusion of the eyelids during embryogenesis (data not shown). By E18.5, in eyes of transgenic mice, regions of the strati®ed surface epithelium invaginated into the underlying stroma ( Fig. 5B±D ) which still exhibited the presence of eosinophilic vascular tissue (Fig. 5D , arrowheads). BrdU-incorporation was predominantly localised to the deepest cells of the invaginated epithelium (Fig. 5C ).
During postnatal development of the transgenic eyes, the cells of the invaginated, intrastromal epithelium progressively differentiated, and by day 21 had acquired a very distinct glandular morphology, predominantly composed of lobules containing serous cells (Fig. 6B,C) . The proximal cells of the invaginated epithelium also differentiated, appearing to form ducts that connected the glandular-like tissue embedded in the stroma to openings on the surface of the eye (Fig. 6B, arrow) . In addition, the cells that remained Fig. 3 . Corneal changes induced by KGF. Sections of non-transgenic (A,C,E) and OVE842 transgenic (B,D,F) El5.5 eyes were stained with haematoxylin and eosin (A±D) or assayed for BrdU incorporation and counterstained with haematoxylin (E,F). The presumptive cornea in transgenic embryos has thickened (B, box, shown at higher magni®cation in D) when compared to non-transgenic littermate controls (A,C), predominantly due to epithelial cell multilayering as well as increased numbers of underlying stromal cells. The transgenic corneal epithelial cells still exhibit enhanced levels of proliferation (BrdU incorporation), predominantly restricted to the basal cells (F, arrows) and vascular tissue is evident in the underlying stroma as eosinophilic staining (D, arrowheads). In eyes of non-transgenic mice, cell proliferation in the cornea is restricted to a few cells (E, arrows) and the underlying stroma is avascular (C). Abbreviations: c, cornea; ce, corneal epithelium; 1, lens; le, lens epithelium; r, retina; s, corneal stroma. Scale bar, (A,B) 800 mm; (C,D) 200 mm; (E,F) 100 mm. Fig. 4 . Keratin 12 expression in eyes of non-transgenic (A) and transgenic (B) E15.5 mice. In eyes of non-transgenic mice, K12 transcripts are detected only in the corneal epithelium (A). This expression pattern in the surface ectoderm demarcates (A, arrows) the differentiating corneal epithelium from the conjunctival epithelium which does not express K12. In eyes of transgenic mice, no transcripts for K12 were detected (B). Abbreviations: c, cornea; 1, lens; r, retina. Scale bar, 400 mm.
as surface epithelium matured differently from the normal corneal epithelium of non-transgenic littermates (see Fig.  6A ), exhibiting distinct translucent mucous-containing (goblet) cells (Fig. 6C, asterisk) , analogous to the conjunctival epithelium which normally lines the inner surface of the eyelids. When compared to non-transgenic mice (Fig.  7A) , the fur surrounding the eyes in transgenic littermates was usually found to be wet or encrusted with dry mucous (Fig. 7B,C) , through the accumulation of a viscous discharge from the surface of the eye; derived from secretions from the newly differentiated glands and mucous cells.
By postnatal day 30, it was clear that ectopic expression of KGF in our transgenic mice had resulted in distinct alterations in features of corneal differentiation (Fig. 8A) . Unlike the composition of the normal cornea (see Fig. 6A ), transgenic corneas contained glandular tissue associated with a disorganised vascularised stroma (Fig. 8A ). This differentiated glandular tissue was comprised of serous acini surrounded by myoepithelial cells (Fig. 8A, arrows) , associated with regularly de®ned ducts (arrowheads); analogous to the serous acini and ducts that make up the normal lacrimal glands associated with the eye (Fig. 8B) .
Normal intraorbital ocular glands (including the lacrimal and harderian glands) differentiate from conjunctival epithelial buds that initially ingress at the conjunctival fornix (junction between the cornea and eyelid) and grow into the mesenchyme of the eye socket ( Fig. 9A, box; 9B ).
During normal gland development, cell proliferation (BrdUincorporation) is predominantly con®ned to the distal cells of this invaginated epithelium (Fig. 9C,D) , similar to the pattern observed in the invaginated surface epithelium in our transgenic mice (see Fig. 5C ).
To determine if KGF stimulation is essential for intraorbital lacrimal gland development we obtained and analysed tissues from adult mice homozygous for a null allele of the KGF gene (Guo et al., 1995) . In these mice, lacrimal glands were present and histologically normal (Fig. 10A ) when compared to lacrimal glands from wild-type mice (Fig.  10B) .
Discussion
In the present study, the ocular phenotype of two lines of transgenic mice overexpressing KGF in the eye (OVE842 and OVE843) were further characterised. Transgene expression was speci®cally directed to the lens of the eye using the a A-crystallin promoter. Using in situ hybridization with riboprobes speci®c for the SV40 region of the transgenic transcripts, transgene expression was found to be restricted to the lens ®bre cells (Fig. 1) , consistent with previous reports using this same promoter (Robinson et al., 1995; Reneker et al., 1995, Lovicu and . Although transgene expression was lens-speci®c, ocular tissues other (A,B) , regions of the proliferating corneal epithelium in transgenic mice invaginated into the underlying corneal stroma (B, box, shown at higher magni®cation in C and D, arrows). Note that the stroma contains eosinophilic-stained vascular tissue (D, arrowheads). BrdU-incorporation in the invaginated epithelium is restricted to the deepest cells (C, brown-staining). The epithelial invagination in the transgenic mice is analogous to the invagination of conjunctival epithelium that normally gives rise to the intraorbital ocular glands including the lacrimal glands (see Fig. 9 ). Abbreviations: 1, lens; c, cornea; e, eyelid; r, retina. Scale bar, (A,B) 400 mm; (C,D) 50 mm.
than the lens, particularly the cornea, exhibited dramatic morphological changes in response to KGF, indicating that this growth factor was ef®ciently secreted by the lens ®bre cells and could in¯uence corneal development. Corneal cells responded to KGF at an earlier embryonic stage than lens cells. This is in contrast to the effects of other FGFs examined in this system (see Lovicu and Overbeek, 1998) , and may re¯ect the differences in KGF receptor levels between these two ocular tissues during ocular morphogenesis (see de Iongh et al., 1997) . In these transgenic mice, lens epithelial cells exited from the cell cycle and differentiated into ®bre cells (see Lovicu and Overbeek, 1998) . Unlike the situation in the lens where epithelial cells underwent changes characteristic of their normal differentiation process, KGF induced presumptive corneal epithelial cells to alter their developmental fate, differentiating into functional glandular tissues.
As early as E14.5, KGF stimulated an increase in BrdUincorporation in the presumptive corneal epithelial cells, indicating an increased rate of cell proliferation. This increase in proliferation resulted in the multilayering and thickening of the epithelium by E15.5. These ®ndings are consistent with earlier studies in vitro that have shown KGF can stimulate proliferation of human corneal epithelial cells (Wilson et al., 1993; Wilson et al., 1994) . In addition, studies with transgenic mice expressing KGF in skin have reported a profound hyperproliferative effect on epidermal growth resulting in a markedly thickened epidermis (Guo et al., 1993) . By embryonic day 18, in our transgenic mice, regions of the multilayered corneal epithelium had invaginated into the underlying stroma (Fig. 5) . Interestingly, not Fig. 6 . Induction of lacrimal-like glands in transgenic corneas. Sections of corneas from non-transgenic (A) and OVE842 transgenic (B,C) eyes from 21-day-old mice were stained with haematoxylin and eosin. (A) The normal cornea is composed of a strati®ed corneal epithelium (ce), underlying stroma (s) and a monolayer of corneal endothelium (arrow). In transgenic mice, ectopic expression of KGF results in alterations in features of corneal differentiation (B,C). The invaginated epithelium has differentiated into glandular epithelium. Prominent lobules that contain numerous serous cells are present as well as regularly de®ned ducts connecting the glandular tissue to the ocular surface (B, arrowhead). The super®cial epithelium resembles normal conjunctiva with the presence of distinctive goblet cells (C, asterisk) . Note that the corneal endothelium is still present in our transgenic mice (B, arrow). Scale bar, (A,B) 100 mm; (C) 50 mm. only was the underlying stroma more disorganised than normal, but it also became vascularised. During postnatal development, the cells of the invaginated corneal epithelium progressively differentiated, acquiring a very distinct glandular morphology by day 21 (Fig. 6 ). This glandular tissue was predominantly composed of lobules containing serous cells surrounded by myoepithelial cells, analogous to normal lacrimal glands (see Fig. 8 , see also Draper et al., 1999) . The proximal cells of the invaginated corneal epithelium also differentiated, forming ducts that connected the lacrimal-like glands to openings on the surface of the cornea.
The surface of the transgenic eyes established a new strati®ed epithelium, histologically distinct from the normal corneal epithelium (see Fig. 6A ) but histologically similar to conjunctival epithelium (see Fig. 6C ) which normally extends from the corneal-scleral junction and lines the inner surface of the eyelids. This newly de®ned surface epithelium contained distinct goblet cells that are characteristic of conjunctival epithelium. This ®nding, that conjunctival epithelium differentiated in place of corneal epithelium was not totally unexpected, taking into consideration some of the molecular events that transpired during ocular morphogenesis in our transgenic mice. When we examined the normal expression of K12 (a marker for corneal epithelial differentiation) during early ocular morphogenesis, we found it to be expressed distinctly in the surface ectoderm that gives rise to the corneal epithelium, demarcated clearly from presumptive conjunctival epithelium which did not express K12 (Fig. 4A) . In contrast, in eyes of our transgenic mice, no K12 transcripts were detected in the surface ectoderm (Fig. 4B) . This indicates that KGF may be negatively regulating K12 expression, perturbing cell fate decisions so that conjunctival epithelium differentiates at the expense of corneal epithelium.
Normal intraorbital ocular glands (including lacrimal and harderian glands) differentiate from surface epithelium that invaginates at the conjunctival fornix, and grows into the vascularised mesenchyme of the eye socket (see Fig. 9 ). The lacrimal and harderian glands can readily be distinguished from each other as harderian glands may stain brown, due to the presence of porphyrins. In essence, in our transgenic mice, the early production of high levels of KGF by the lens led to a similar invagination and growth of lacrimallike glands into the underlying vascularised mesenchyme. Furthermore, during normal intraorbital ocular gland development, incorporation of BrdU is predominantly con®ned to the distal cells of the invaginating epithelium (Fig. 9C,D) , similar to the pattern observed in the invaginating surface epithelium in our transgenic mice expressing KGF (see Fig.  5C ).
A factor that may also be in¯uencing the differentiation of the corneal epithelium into conjunctiva is the vascularisation of the underlying stroma. Tseng et al. (1984) reported that conjunctival differentiation and the density of goblet cells in conjunctiva are closely tied to the degree of vascularisation of the underlying stroma. The normal corneal stroma is avascular, whereas the conjunctival stroma is highly vascularised. In our transgenic mice, KGF induced the vascularisation of the normally avascular corneal stroma which in turn may have in¯uenced the fate of the overlying epithelial cells.
KGF has recently been reported to be expressed by the lacrimal gland (see Wilson et al., 1999) and is also expressed in the mesenchyme of the eye socket that surrounds it . The embryonic surface ectoderm that normally gives rise to both the corneal epithelium and to the conjunctiva (including the presumptive lacrimal gland) expresses high levels of the KGF receptor (Orr-Urtreger et al., 1993; Finch et al., 1995; de Iongh et al., 1997) . In the present study we have demonstrated that overexpression of KGF in embryonic lenses of transgenic mice induces the formation of conjunctiva and lacrimal-like glands from the embryonic corneal epithelium. This result indicates that the KGF receptor (FGFR2IIIb) is likely to play a key role in vivo as a mediator of proliferation and differentiation of lacrimal gland cells during embryogenesis. Although these data are consistent with KGF being an important mesenchymal-derived signal for lacrimal gland differentiation, other FGFs cannot be excluded. In order to assess whether KGF is indeed the endogenous inductive signal, we obtained and analysed tissues from adult mice homozygous for a null allele of the KGF gene (Guo et al., 1995) . Lacrimal glands were present and histologically normal in these mice (Fig. 10) , indicating that another FGF family member(s) can provide the endogenous differentiation signal.
As KGF speci®cally binds only one FGF receptor isoform (FGFR2IIIb; Bottaro et al., 1990) , results from the present study suggest that activation of this FGFR2 isoform must lead to downstream signalling events suf®cient to induce competent surface ectoderm to form lacrimal-like glands. Support for this comes from a recent transgenic study where FGF-3 was expressed in a lens-speci®c fashion, similar to the present study. FGF-3 also activates the FGFR2IIIb isoform (Mathieu et al., 1995; Ornitz et al., 1996) and the presence of intraocular glandular structures were also reported in these transgenic mice (Robinson et al., 1998) . It should be noted, however, that unlike the present study whereby glandular tissue differentiation followed an ordered process in response to KGF, the appearance of glandular tissue in eyes of transgenic mice expressing FGF-3 may have resulted from the migration of extraocular glandular tissue into the eye, facilitated by the rupture of the cornea during an earlier stage in development (Robinson et al., 1998) .
Recent cloning and characterisation of FGF-10 have shown it to be the most closely related FGF family member to KGF, possessing very similar biological and biochemical properties, as well as speci®cally interacting with the same high af®nity receptor (Yamasaki et al., 1996; Igarashi et al., 1998) . As a means of identifying ligands with redundant or overlapping functions to KGF, our future studies will be aimed at determining whether FGF-10 is expressed in and around the eye and whether it can also stimulate ectopic gland formation when overexpressed in transgenic mice.
Our present studies have shown that presumptive corneal epithelium appears to be competent to form lacrimal-like glands. This KGF-induced differentiation is apparently restricted only to the head surface ectoderm competent to develop ocular tissues as in other studies ectopic expression of KGF in the epidermal layer of transgenic mice does not induce lacrimal gland formation (Guo et al., 1993) . Competence may be speci®ed in, and restricted to, the ocular surface ectoderm through the localised expression of transcription factors, in particular Pax-6, a paired box gene thought to be essential for eye development (Hill et al., 1992; Quinn et al., 1996; Graw, 1996; Cvekl and Piatigorsky, 1996) . During normal development, expression of Pax-6 in surface ectoderm is restricted to the area of the presumptive eye and its adnexal tissues (Walther and Gruss, 1991) . The fact that lacrimal gland induction normally occurs only at a speci®c location around the eye also implies that expression of the inductive signal must be localised. The current study highlights the fact that the correct spatial and temporal expression of FGFs is an important mechanism governing normal embryonic growth and development.
Experimental procedures
All experimental procedures with transgenic mice were performed in accordance with the recommendations of the NIH Guide for the Care and Use of Laboratory Animals using protocols reviewed by the Animal Research Committee of the Baylor College of Medicine.
Transgenic mice
The transgenic mice used in the present study were generated using a human cDNA for KGF linked to a murine aAcrystallin promoter vector which contains an SV40 intron and polyadenylation region, as previously described (Lovicu and Overbeek, 1998) . Pregnant mice at various stages following copulation with transgenic mice were sacri®ced and embryos or foetuses were delivered by caesarean section as previously described (see Lovicu and Overbeek, 1998) . Transgenic animals were screened by polymerase chain reaction (PCR) using genomic DNA isolated from mouse tails (Hogan et al., 1994) and primers speci®c for the SV40 sequences (see Lovicu and Overbeek, 1998) .
Histology
Embryonic and foetal heads or postnatal eyes were removed, ®xed overnight in 10% phosphate-buffered formalin, dehydrated and processed for routine histology. For histochemical analysis, 6-mm thick sections were stained with haematoxylin and eosin.
In situ hybridization
Transgene expression in the eye was examined by in situ hybridization using a [ 35 S]-UTP-labelled riboprobe containing the SV40 sequences of the transgene as described previously (Robinson et al., 1995) . Hybridizations were performed on sections of embryos collected from timed pregnancies (see above). Hybridization slides coated with photographic emulsion were exposed for up to 7 days before developing and counterstaining with Harris haematoxylin.
K12 mRNA expression in the eye was assessed by nonradioactive in situ hybridization using a digoxygeninlabelled riboprobe coding for the full length K12 cDNA, as previously described (Kao et al., 1996) . Hybridization was performed on sections of eyes from transgenic mice and wild-type littermates at embryonic day 15.5. Following post-hybridization high stringency washes, tissue sections were incubated overnight at 48C with an anti-digoxygenin antibody conjugated to alkaline phosphatase (Boehringer Mannheim, Indianapolis, IN). The hybridization signal was visualised using 5-nitroblue tetrazolium chloride according to manufacturer's speci®cations (Boehringer Mannheim).
Immunohistochemistry
For examining the patterns of cell proliferation (cells entering S-phase), incorporation of 5-bromo-2 H -deoxyuridine (BrdU) was analysed using immunohistochemistry as previously described (Lovicu and Overbeek, 1998) . In brief, pregnant mice were injected intraperitoneally with 100 mg/g BrdU (Sigma, St. Louis, MO) supplemented with one tenth the concentration of 5-¯uoro-2 H -deoxyuridine (Sigma). One hour following the injection, foetal heads were collected, ®xed and processed as previously described (see Lovicu and Overbeek, 1998) . To detect BrdU incorporation, 6-mm thick sections of tissues were hydrated, quenched with 3% H 2 O 2 in 10% methanol and incubated with 0.02% pepsin (20 minutes at 378C). Following pepsin digestion, sections were treated with 2 N HCl, neutralised with 0.1 M sodium borate, pH 8.5, and rinsed in PBS. Sections were then incubated for 30 min in 3% normal horse serum followed by an overnight incubation at 48C with a monoclonal anti-BrdU antibody (Dako, Carpinteria, CA) diluted 1:50 with PBS. Binding of the primary antibody was visualised using biotinylated secondary antibodies and substrate kits according to manufacturer's speci®cations (Vector Laboratories, Burlingame, CA). Sections were counterstained with Harris haematoxylin.
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